comparemela.com

Latest Breaking News On - Pfizer ventures - Page 1 : comparemela.com

Advanced autoclave technology supports pioneering genetic research at Oxford Science Park

Nucleome Therapeutics, a leading UK biotech firm that specialises in decoding the dark genome's non-coding DNA regions to develop precision medicines for autoimmune diseases like multiple sclerosis, lupus, and rheumatoid arthritis, purchase LTE research-grade autoclave to assist with research. Click to read more.

United-kingdom
Anthony-campbell-carr
Paul-brackstone
Oxford-university-bioescalator
Anthony
Oxford-science-enterprises
Nucleome-therapeutics
Oxford-university
Pfizer-ventures
Old-road-campus
Oxford-science-park
Schrodinger-building

Grey Wolf Receives additional $50M in Series B Financing

Grey Wolf Receives additional $50M in Series B Financing
zenopa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zenopa.com Daily Mail and Mail on Sunday newspapers.

Grey-wolf-therapeutics
Pfizer-ventures
Andera-partners

STORM Therapeutics to Present Interim Phase 1 Clinical Data on its METTL3 RNA Methyltransferase Inhibitor STC-15 at ASCO 2024

STC-15 is the first METTL3 inhibitor to enter clinical development Clinical data will include safety, pharmacology, target modulation, and clinical activity CAMBRIDGE, England, May

United-states
San-antonio
Texas
Chicago
Illinois
Cambridge
Cambridgeshire
United-kingdom
American
Justin-moser
Jordi-rodon-ahnert
Kyriakos-papadopoulos

Why government regulation isn't always a clear cut issue in tech

Why government regulation isn't always a clear cut issue in tech
fortune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fortune.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Sweden
Mexico
Mexico-city
Distrito-federal
Greenrock
California
Stockholm
Russia
Singapore
United-kingdom

vimarsana © 2020. All Rights Reserved.